Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
… analysis. Despite initial response to Ewing-like chemotherapy (vincristine, doxorubicin and cyclophosphamide regimen), the disease rapidly…
… frequently received corticosteroids (79.3% vs 67.9%, p=0.003), cyclophosphamide (43.4% vs 26%, p<0.001) and azathioprine (38.5% vs 22.3%, p=0.0…
…erim dexamethasone provided relief. Intensive chemotherapy with rituximab, cyclophosphamide, doxorubicin, vincristine and methotrexate/if…
… plus rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone, he had achieved a complete metabolic response by positron-emis…
…h right sentinel lymph node biopsy (SLNB), followed by adjuvant docetaxel–cyclophosphamide chemotherapy. Radiotherapy was avoided given t…
…ose receiving cyclophosphamide (CYC) and 20% of those receiving mycophenolate mofetil (MMF) achieved a renal response after 24 weeks. There were no s…
…w disease activity state (46.42%) and tapering glucocorticoids. Cyclophosphamide use was associated with greater clinical improvement (r=0.284; …
…and poor prognosis. Adding immune checkpoint inhibitors such as pembrolizumab to neoadjuvant chemotherapy has improved pathological response …
…64.4%) AT and 25 (55.6%) HP.The AT most frequently involved was paclitaxel (50; 11.3%), followed by cyclophosphamide (37; 8.4%), doxorubic…
…ease with highly variable manifestations. New therapies such as belimumab appear to reduce cumulative organ damage and disease flares, im…
…topenias, high-titer ANA and anti-dsDNA led to SLE diagnosis so hydroxychloroquine and glucocorticoid were started. In 2014, due to high proteinur…
… proliferation; suppression appeared in one patient at M3 after cyclophosphamide. Compared to functionally suppressive MDSC obtains from other s…